Patent · US Active

Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives

US8383365B2 · kind B2 · utility

48Cited by
164References
60Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2011
Grant dateFeb 26, 2013
Priority date—
Expiry dateMar 18, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified FGF-21 polypeptides and uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.